The price of IRMD is predicted to go up -20.67%, based on the high correlation periods with KAI. The similarity of these two price pattern on the periods is 98.36%.
IRMD
KAI
Down: -20.67%Similarity: 98.36%
IRMD Revenue Forecast
IRMD EPS Forecast
IRMD FAQs
What is IRMD revenue forecast for next quarter?
The market consensus for IRMD's revenue in the upcoming quarter is projected to be approximately $19.332M USD.
Roth MKM raised the firm's price target on iRadimed to $72 from $60 and keeps a Buy rating on the shares. The company reported solid Q4 revenue of $19.4M, representing an 11% y/y increase while beating the firm's estimate and consensus of $19.1M as well as previously issued guidance of $19.2M-$19.4M for FY24, the analyst tells investors in a research note. Monitoring system bookings also improved in Q4, signaling early traction from iRadimed's renewed salesforce focus on this product category, the firm adds.